Ionis appoints C. Frank Bennett, Ph.D., to chief scientific officer and promotes Eric E. Swayze, Ph.D., to senior vice president of research
- Wednesday, December 18, 2019, 7:19
- Business
- Add a comment
CARLSBAD, Calif., Dec. 18, 2019 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, today announced the appointments of C. Frank Bennett, Ph.D., as chief scientific officer, and Eric E. Swayze, Ph.D., as senior vice president of research,…
About the Author
adminasapcorp has written 42190 stories on this site.